Tiago Cordeiro Felismino
accamargo.org.br

Tiago Cordeiro Felismino: Discussing the Role of Immunotherapy in MSI-H/dMMR CRC at SBOC 2025

Tiago Cordeiro Felismino, Chief of Upper Gastrointestinal Oncology at A.C. Camargo Cancer Center, shared a post on LinkedIn:

“Recent participation in the Congress of the Brazilian Society of Clinical Oncology 2025.

Opportunity to discuss the role of immunotherapy in colorectal cancer with high microsatellite instability (MSI-H/dMMR).”

Tiago Cordeiro Felismino: Discussing the Role of Immunotherapy in MSI-H/dMMR CRC at SBOC 2025

More posts featuring Brazilian Society of Clinical Oncology.